Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing drugs to address unmet medical needs. The company was founded in 1997 and is based in San Diego, California.
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on January 15, 2021, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to purchase an aggregate of 16,950 shares of its common stock and 3,470 inducement restricted stock units ("RSUs"). The inducement stock options and RSUs have a grant date and vesting commencement date of January 15, 2021 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).
Arena Pharmaceuticals, Inc. (ARNA) 39th Annual J.P. Morgan Healthcare Conference January 13, 2021 01:00 PM ET Company Participants Amit Munshi - President and Chief Executive Officer Conference Call Participants Jess Fye - JP Morgan Presentation Jess Fye Good morning everyone. My name is Jess Fye. I'm one of the senior...
SA Transcripts on Seeking Alpha | January 13, 2021
Investment Thesis Arena Pharmaceuticals (ARNA) stock is up 78% in 2020, and the developer of G protein-coupled receptors ("GCPRs") ought to have an exciting year in store, with multiple data readouts due in relation to its lead asset Etrasimod - an oral Sphingosine-1-phosphate ("S1P") Receptor Modulator indicated for multiple immune-mediated...
Edmund Ingham on Seeking Alpha | December 29, 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021, at 10:00 AM ET.
The global Anti-obesity Drugs market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future